BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Divis Laboratories Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
532488
ISIN Demat
INE361B01024
Book Value (Rs)
629.4942217
NSE Symbol
DIVISLAB
Divident Yield %
0.46
Market Cap
(Rs In Cr.)
174,543
P/E (TTM)
65.56
EPS (TTM)
100.29
Face Value
(Rs)
2
Back
Divi's Laboratories consolidated net profit declines 1.02% in the December 2025 quarter
11-Feb-26   Hrs IST

Net profit of Divi's Laboratories declined 1.02% to Rs 583.00 crore in the quarter ended December 2025 as against Rs 589.00 crore during the previous quarter ended December 2024. Sales rose 12.29% to Rs 2604.00 crore in the quarter ended December 2025 as against Rs 2319.00 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales2604.002319.00 12
OPM %34.1832.04 -
PBDT972.00825.00 18
PBT854.00726.00 18
NP583.00589.00 -1

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)